Adverse reactions in immunotherapy are different from chemotherapy and radiotherapy. They usually manifest as a series of inflammatory diseases similar to autoimmune diseases, which are called immune-related adverse events (irAEs).

Has the following characteristics:

Affecting one or several different organ systems.

Immune-related adverse events may occur at any time during or after treatment.

The severity of adverse events ranges from asymptomatic to serious or life-threatening, and they may accumulate during treatment.

Combination therapy may increase the severity of adverse events.

Common adverse immune reactions

Common adverse immune reactions include rash, itching and fatigue. More serious will produce inflammation: pneumonia, pancreatitis, dermatitis and so on. Very few patients will have fatal adverse reactions such as myocarditis and hypophysitis.

How to prevent &; Coping with adverse immune response

At present, there is no particularly effective prevention method. In order to ensure the safety of patients, hospitals specializing in immunotherapy will regularly monitor the relevant indicators of patients, and usually require patients to provide inspection reports within one week before treatment.

Immunotherapy is the least hidden danger among all cancer treatment methods. Immunotherapy is to fight against tumor cells by improving the immune mechanism in human body.